Abraxane and neutropenia Patient Reports February 11, 2012

Abraxane Side Effects Report #6091356-5
Abraxane side effect was reported by a Health Professional from UNITED STATES on Feb 19, 2009. Female patient, weighting 127.4 lb, was diagnosed with metastatic neoplasm and was treated with Abraxane. After drug was administered, patient experienced the following side effects: fatigue, neutropenia, pulmonary embolism . Abraxane dosage: 168 MG D1,D8, D15/CYCLE 042. During the same period patient was treated with VANDETANIB, FENTANYL TRANSDERMAL SYSTEM, ADVIL, MEGACE, TOPROL. Patient was hospitalized. Patient recovered.

Abraxane Side Effects Report #5061113-7
Abraxane side effect was reported by a Health Professional from UNITED STATES on July 05, 2006. Female patient, 69 years of age, weighting 174.0 lb, was diagnosed with breast cancer metastatic and was treated with Abraxane. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anaemia, anorexia, aspartate aminotransferase increased, blood alkaline phosphatase increased, neutropenia, weight decreased. Abraxane dosage: (260 MG/M2, EVERY 3 WEEKS), INTRAVENOUS. During the same period patient was treated with ZOMETA, COMPAZINE, TOPROL, ASPIRIN. Patient recovered.

Abraxane Side Effects Report #5083644-6
Abraxane side effect was reported by a Health Professional from UNITED STATES on July 31, 2006. Female patient, 69 years of age, weighting 174.0 lb, was diagnosed with breast cancer metastatic and was treated with Abraxane. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anaemia, anorexia, aspartate aminotransferase increased, blood alkaline phosphatase increased, neutropenia, weight decreased. Abraxane dosage: unknown. During the same period patient was treated with ZOMETA, COMPAZINE, TOPROL, ASPIRIN. Patient recovered.

Abraxane Side Effects Report #5051514-5
Abraxane side effect was reported by a Health Professional from UNITED STATES on June 23, 2006. Male patient, 66 years of age, weighting 254.0 lb, was diagnosed with breast cancer metastatic, anaemia, neutropenia and was treated with Abraxane. After drug was administered, patient experienced the following side effects: cardiac failure congestive, chest pain , dyspnoea, neutropenia, palpitations, pulmonary congestion, sinus tachycardia, supraventricular tachycardia, thrombocytopenia. Abraxane dosage: LAST DOSE 28-APR-2006 (175 MG/M2, EVERY 3 WEEKS), INTRAVENOUS DRIP. During the same period patient was treated with PROCRIT, CYTOXAN, DOXORUBICIN, NEUPOGEN, ASPIRIN, LIPITOR, LORTAB, FEMARA. Patient was hospitalized. Patient recovered.


Abraxane Side Effects Report #5131458-0
Abraxane side effect was reported by a Health Professional from UNITED STATES on Oct 02, 2006. Male patient, 66 years of age, weighting 223.8 lb, was diagnosed with breast cancer metastatic, anaemia of malignant disease, hypercholesterolaemia, neutropenia and was treated with Abraxane. After drug was administered, patient experienced the following side effects: anaemia, cardiac failure congestive, chest pain , dehydration, dyspnoea, musculoskeletal chest pain, neutropenia, palpitations, pneumonia . Abraxane dosage: LAST DOSE PRIOR TO FIRST EVENT 28-APR-2006 (175 MG/M2, EVERY 3 WEEKS), INTRAVENOUS DRIP. During the same period patient was treated with PROCRIT, CYTOXAN, DOXORUBICIN, ASPIRIN, NEUPOGEN, LIPITOR, LORTAB. Patient was hospitalized. Patient recovered.

Abraxane Side Effects Report #5085472-4
Abraxane side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 03, 2006. Female patient, 62 years of age, was diagnosed with breast cancer metastatic and was treated with Abraxane. After drug was administered, patient experienced the following side effects: alopecia, hypoaesthesia facial, nausea , neutropenia, sepsis . Abraxane dosage: 260 MG/M2 1 DOSE (260 MG/M2), INTRAVENOUS DRIP. Patient was hospitalized. Patient recovered.

Abraxane Side Effects Report #5085812-6
Abraxane side effect was reported by a Health Professional from UNITED STATES on Aug 03, 2006. Female patient, 62 years of age, weighting 179.0 lb, was diagnosed with breast cancer metastatic and was treated with Abraxane. After drug was administered, patient experienced the following side effects: alopecia, hypoaesthesia facial, nausea , neutropenia, sepsis . Abraxane dosage: 260 MG/M2/1 DOSE (260 MG/M2), INTRAVENOUS DRIP. Patient was hospitalized. Patient recovered.

Abraxane Side Effects Report #4694761-4
Abraxane side effect was reported by a Health Professional from on June 01, 2005. Female patient, 62 years of age, was diagnosed with breast cancer metastatic and was treated with Abraxane. After drug was administered, patient experienced the following side effects: activities of daily living impaired, asthenia, bone pain, fall , myalgia, neutropenia, white blood cell count decreased. Abraxane dosage: 500 MG (260 MG/M2, EVERY 3 WEEKS), INTRAVENOUS DRIP. During the same period patient was treated with ANZEMET, XANAX. Patient recovered.

Abraxane Side Effects Report #5664768-9
Abraxane side effect was reported by a Physician from UNITED STATES on Feb 26, 2008. Female patient, 61 years of age, weighting 187.0 lb, was diagnosed with breast cancer metastatic and was treated with Abraxane. After drug was administered, patient experienced the following side effects: blood sodium decreased, colitis ischaemic, endotoxic shock, metastases to lung, neutropenia, pneumonia , renal failure acute, septic shock. Abraxane dosage: LAST DOSE (200 MG) PRIOR TO SAE ON 05-FEB-2008 (CYCLE 5) (WEEKLY, 3WKS ON THEN 1 WK. OFF), INTRAVENO. During the same period patient was treated with KYTRIL, DECADRON, TOPROL, ACIPHEX, LASIX, GABAPENTIN, CYMBALTA, ZAROXOLYN. Patient was hospitalized. Patient recovered.


Abraxane Side Effects Report #5407897-7
Abraxane side effect was reported by a Physician from UNITED STATES on July 26, 2007. Female patient, 49 years of age, was diagnosed with breast cancer metastatic and was treated with Abraxane. After drug was administered, patient experienced the following side effects: mucosal inflammation, neutropenia, palmar-plantar erythrodysaesthesia syndrome, recall phenomenon, white blood cell count decreased. Abraxane dosage: 225 MG/M2 INTRAVENOUS. During the same period patient was treated with NEULASTA, ZOMETA, ALTACE, DOXIL, GEMZAAR. Patient was hospitalized. Patient recovered.

Abraxane Side Effects Report #5096641-1
Abraxane side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 17, 2006. Female patient, 47 years of age, was diagnosed with breast cancer metastatic and was treated with Abraxane. After drug was administered, patient experienced the following side effects: dehydration, neutropenia. Abraxane dosage: 155MG X 1 DOSE (EVERY 3 WEEKS) INTRAVENUOS DRIP. During the same period patient was treated with AVASTIN, CARBOPLATIN. Patient was hospitalized. Patient recovered.

Abraxane Side Effects Report #5096988-9
Abraxane side effect was reported by a Health Professional from UNITED STATES on Aug 17, 2006. Male patient, 47 years of age, weighting 112.0 lb, was diagnosed with breast cancer metastatic and was treated with Abraxane. After drug was administered, patient experienced the following side effects: dehydration, liver function test abnormal, neutropenia. Abraxane dosage: 155MG X 1 DOSE (EVERY 3 WEEKS), INTRAVENOUS DRIP. During the same period patient was treated with AVASTIN, CARBOPLATIN. Patient was hospitalized. Patient recovered.

Abraxane Side Effects Report #5097127-0
Abraxane side effect was reported by a Physician from UNITED STATES on Aug 17, 2006. Female patient, 46 years of age, weighting 182.0 lb, was diagnosed with breast cancer metastatic and was treated with Abraxane. After drug was administered, patient experienced the following side effects: mucosal inflammation, neutropenia, oesophagitis, oral candidiasis, thrombocytopenia. Abraxane dosage: 507 MG DAY/1 DOSE, INTRAVENOUS DRIP. Patient was hospitalized. Patient recovered.

Abraxane Side Effects Report #5049775-1
Abraxane side effect was reported by a Health Professional from UNITED STATES on June 22, 2006. Female patient, 45 years of age, weighting 160.0 lb, was diagnosed with breast cancer metastatic and was treated with Abraxane. After drug was administered, patient experienced the following side effects: catheter related infection, dehydration, mucosal inflammation, neutropenia, oral mucosal blistering, rash , sepsis , thrombocytopenia. Abraxane dosage: unknown. During the same period patient was treated with CARBOPLATIN, NEULASTA. Patient was hospitalized. Patient recovered.


Abraxane Side Effects Report #5085086-6
Abraxane side effect was reported by a Health Professional from UNITED STATES on Aug 03, 2006. Female patient, 41 years of age, was diagnosed with breast cancer metastatic and was treated with Abraxane. After drug was administered, patient experienced the following side effects: dysarthria, hypoaesthesia facial, neutropenia, sepsis . Abraxane dosage: 1 DOSE (260 MG/M2), INTRAVENOUS DRIP. Patient was hospitalized. Patient recovered.

Abraxane Side Effects Report #5085466-9
Abraxane side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 03, 2006. Female patient, 41 years of age, was diagnosed with breast cancer metastatic and was treated with Abraxane. After drug was administered, patient experienced the following side effects: dysarthria, hypoaesthesia facial, neutropenia, sepsis . Abraxane dosage: 1 DOSE (260 MG/M2), INTRAVENOUS DRIP. Patient was hospitalized. Patient recovered.

Abraxane Side Effects Report #6035351-0
Abraxane side effect was reported by a Health Professional from UNITED STATES on Jan 09, 2009. Female patient, weighting 166.4 lb, was diagnosed with adenocarcinoma pancreas and was treated with Abraxane. After drug was administered, patient experienced the following side effects: mucosal inflammation, neutropenia. Abraxane dosage: 174 MG D1,D8,D15/CYCLE 042. During the same period patient was treated with VANDETANIB, LOVENOX, ASCORBIC ACID. Patient was hospitalized. Patient recovered.

Abraxane Side Effects Report #6062448-1
Abraxane side effect was reported by a Health Professional from UNITED STATES on Feb 02, 2009. Female patient, weighting 153.0 lb, was diagnosed with adenocarcinoma pancreas and was treated with Abraxane. After drug was administered, patient experienced the following side effects: culture urine positive, neutropenia, pyrexia. Abraxane dosage: 134 MG D1, D8, 115/CYCLE 042. During the same period patient was treated with VANDETANIB, LOVENOX, ASCORBIC ACID, OMEPRAZOLE. Patient was hospitalized. Patient recovered.